Catherine Bollard's most recent trade in Cabaletta Bio Inc was a trade of 22,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cabaletta Bio Inc | Catherine Bollard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Catherine Bollard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Cabaletta Bio Inc | Catherine Bollard | Director | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 18 Oct 2022 | 1,000 | 1,000 (0%) | 0% | 1.0 | 994 | Common Stock |
Cabaletta Bio Inc | Catherine Bollard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to buy) | |
Cabaletta Bio Inc | Catherine Bollard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 22,000 | 22,000 | - | - | Stock Option (Right to buy) |